The Role of hsTnI Algorithms at Outpatient Point-of-Care Sites

Helping Enhance Patient Care and Departmental Efficiency with POC Testing

Chest pain remains one of the most common and challenging symptoms encountered in emergency departments (EDs). Traditional evaluation pathways often result in unnecessary admissions, extensive testing, and delayed decision-making. With the advent of high-sensitivity troponin I (hsTnI) assays, clinicians can now more confidently rule out acute myocardial infarction (AMI) and safely discharge low-risk patients—helping to enhance both patient care and departmental efficiency.

In this webinar, Dr. James McCord, an experienced cardiologist and thought leader in cardiac diagnostics, will discuss how hsTnI testing at the point of care is transforming risk stratification in both hospital and outpatient environments. Using real-world examples and clinical insights, he will address common misconceptions, serial testing strategies, and how POC access to hsTnI can support decision-making in freestanding EDs and urgent care centers.

Learning Objectives

This webinar will help you:

• Discuss the clinical impact of high-sensitivity troponin I (hsTnI) in emergency care settings
• Identify how hsTnI supports efficient and safe discharge decisions, especially in resource-limited environments
• Discover the utility of hsTnI testing at the point of care in freestanding EDs and urgent care
• Recognize implementation challenges and strategies to maintain consistency between POC and central lab testing

Register Now

Fisher Healthcare is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.™ Program. One P.A.C.E.™ credit-hour will be provided for this complimentary basic level program.

Dr. James McCord, Professor of Medicine

Dr. James McCord is a professor of medicine at the Wayne State School of Medicine in Detroit, MI. He currently serves as the associate program director for cardiology research. His area of clinical research includes cardiac biomarkers and the assessment of patients in the emergency department for possible acute coronary syndrome and heart failure.